Cambridge Investment Research Advisors, Inc. Compugen LTD Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 27, 2020	SELL	$6.97 - $17.12 $76,495 - $187,892	-10,975 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$5.79 - $11.83 $63,545 - $129,834	10,975 New	10,975 $79,000
Q1 2018 May 09, 2018	SELL	$2.5 - $4.45 $28,937 - $51,508	-11,575 Closed	0 $0
Q4 2017 Feb 22, 2018	SELL	$2.35 - $4.0 $4,700 - $8,000	-2,000 Reduced 14.73%	11,575 $0
Q3 2017 Nov 07, 2017	SELL	$2.75 - $3.95 $24,530 - $35,234	-8,920 Reduced 39.65%	13,575 $52,000
Q2 2017 Aug 08, 2017	BUY	N/A	22,495	22,495 $85,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.3M

Call Options Held

191K

Put Options Held

135K

Silverarc Capital Management, LLC

1.5M
Shares

$2.46 Million
0.72% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.29M
Shares

$2.11 Million
0.0% of portfolio
Taylor Frigon Capital Management LLC

1.2M
Shares

$1.97 Million
1.09% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

1.09M
Shares

$1.79 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

1.02M
Shares

$1.67 Million
0.0% of portfolio

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account